BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3925659)

  • 1. Group B streptococcus type II antisera have anti-galactan specificities.
    Uhlenbruck G; Lütticken R; Böhmer G; Janssen E; Pulverer G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):179-87. PubMed ID: 3925659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of group B streptococcal type-specific polysaccharides with wheat germ agglutinin and other lectins.
    Gray BM; Dillon HC; Pritchard DG
    J Immunol Methods; 1984 Aug; 72(1):269-77. PubMed ID: 6205097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of B streptococcal type antigens among streptococci of serological groups B, G and L.
    Wibawan IW; Lämmler C
    Zentralbl Bakteriol; 1990 Sep; 273(4):471-7. PubMed ID: 2123387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serologic cross reactions of group B streptococci].
    Uhlenbruck G; Lütticken R; Bäz K; Böhmer G
    Immun Infekt; 1985 Nov; 13(6):276-82. PubMed ID: 2416673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar combining specificities of invertebrate precipitins and mouse myeloma protein J 539 for beta-(1leads to6)-galactans.
    Eichmann K; Uhlenbruck G; Baldo BA
    Immunochemistry; 1976 Jan; 13(1):1-6. PubMed ID: 943369
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.
    Colling RG; Pearson TC; Brown JC
    Infect Immun; 1983 Jul; 41(1):205-13. PubMed ID: 6345390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
    VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
    J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    Fischer GW; Lowell GH; Crumrine MH; Bass JW
    J Exp Med; 1978 Sep; 148(3):776-86. PubMed ID: 29937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snake venom lectins: a new group of T- and B-cell mitogenic anti-galactans.
    Helmbold W; Prokop O; Uhlenbruck G; Böhmer G; Lütticken R
    Biomed Biochim Acta; 1985; 44(11-12):K91-6. PubMed ID: 3911952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci.
    Kane JA; Karakawa WW
    Infect Immun; 1978 Mar; 19(3):983-91. PubMed ID: 76609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological cross reactions between polysaccharides of Streptococci groups A and L].
    Kolesnikova VIu; Borodiiuk NA; Liampert IM
    Biull Eksp Biol Med; 1979 May; 87(5):433-6. PubMed ID: 378288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of antibodies to the beta-(1-->6)-galactotetraosyl group and their interaction with arabinogalactan-proteins.
    Kikuchi S; Ohinata A; Tsumuraya Y; Hashimoto Y; Kaneko Y; Matsushima H
    Planta; 1993; 190(4):525-35. PubMed ID: 7763824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of anti-group B streptococcal monoclonal antibodies.
    Harris MC; Douglas SD; Kolski GB; Polin RA
    Clin Immunol Immunopathol; 1982 Sep; 24(3):342-50. PubMed ID: 6813008
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.
    Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL
    J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoblot analysis of bacterial polysaccharides: application to the type-specific polysaccharides of Streptococcus suis and Streptococcus agalactiae.
    Tikkanen K; Häyrinen J; Pelkonen S; Finne J
    J Immunol Methods; 1995 Dec; 187(2):233-44. PubMed ID: 7499882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical cross-reactions between type III group B Streptococcus and type 14 Streptococcus pneumoniae.
    Crumrine MH; Fischer GW; Balk MW
    Infect Immun; 1979 Sep; 25(3):960-3. PubMed ID: 40876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants.
    Kasper DL; Goroff DK; Baker CJ
    J Immunol; 1978 Sep; 121(3):1096-105. PubMed ID: 80423
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative measurement of precipitating antibodies and standardization of Streptococcus group B antisera by the reverse radial immunodiffusion technique.
    George JR; Harrell WK
    Bull World Health Organ; 1974; 51(3):245-8. PubMed ID: 4218968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody.
    Mackie EB; Brown KN; Lam J; Costerton JW
    J Bacteriol; 1979 May; 138(2):609-17. PubMed ID: 374399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.